CVE-2022-47376
CVE-2022-47376 is a high-severity vulnerability in Bd Alaris Infusion Central with a CVSS 3.x base score of 7.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-522.
Key facts
- Severity: High (CVSS 3.x base score 7.3)
- EPSS exploit prediction: 0% (6th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-522
- Affected product: Bd Alaris Infusion Central
- Published:
- Last modified:
Description
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.
Frequently asked questions
- What is CVE-2022-47376?
- The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.
- How severe is CVE-2022-47376?
- CVE-2022-47376 has a CVSS 3.x base score of 7.3, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability low.
- Is CVE-2022-47376 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (6th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2022-47376?
- CVE-2022-47376 affects Bd Alaris Infusion Central. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2022-47376?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2022-47376 published?
- CVE-2022-47376 was published on 2023-06-13 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:bd:alaris_infusion_central:*:*:*:*:*:*:*:*
Other CWE-522 (Insufficiently Protected Credentials) vulnerabilities
- CVE-2026-7312 — Critical (CVSS 10.0): CWE‑522: Insufficiently Protected Credentials in web services in Progress Sitefinity version from 14.0.7700 to…
- CVE-2026-29128 — Critical (CVSS 10.0): IDC SFX2100 Satellite Receiver firmware ships with multiple daemon configuration files for routing components (e.g.,…
- CVE-2025-54863 — Critical (CVSS 10.0): Radiometrics VizAir is vulnerable to exposure of the system's REST API key through a publicly accessible configuration…
- CVE-2024-12799 — Critical (CVSS 10.0): Insufficiently Protected Credentials vulnerability in OpenText Identity Manager Advanced Edition on Windows, Linux, 64…
- CVE-2024-51545 — Critical (CVSS 10.0): Username Enumeration vulnerabilities allow access to application level username add, delete, modify and list…
- CVE-2023-1778 — Critical (CVSS 10.0): This vulnerability exists in GajShield Data Security Firewall firmware versions prior to v4.28 (except v4.21) due to…
Browse all CWE-522 (Insufficiently Protected Credentials) vulnerabilities →